Cannara Biotech (TSXV:LOVE) Other Operating Expense : C$0.90 Mil (TTM As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Other Operating Expense?

Cannara Biotech's Other Operating Expense for the three months ended in Feb. 2025 was C$0.28 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2025 was C$0.90 Mil.

Cannara Biotech's quarterly Other Operating Expense increased from Aug. 2024 (C$0.10 Mil) to Nov. 2024 (C$0.28 Mil) and increased from Nov. 2024 (C$0.28 Mil) to Feb. 2025 (C$0.28 Mil).

Cannara Biotech's annual Other Operating Expense declined from Aug. 2022 (C$1.07 Mil) to Aug. 2023 (C$0.66 Mil) but then increased from Aug. 2023 (C$0.66 Mil) to Aug. 2024 (C$0.97 Mil).

Cannara Biotech Other Operating Expense Historical Data

The historical data trend for Cannara Biotech's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Other Operating Expense Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Other Operating Expense

Get a 7-Day Free Trial

1.58

0.79

1.07

0.66

0.97

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Other Operating Expense	Get a 7-Day Free Trial															0.23	0.24	0.10	0.28	0.28

Cannara Biotech Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.90 Mil.

Cannara Biotech Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Olymbec Investments Inc.	10% Security Holder
Nicholas Sosiak	Senior Officer
Donald John Olds	Director
Derek Elan Stern	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder